August 3, 2025 August 3, 2025Categories News StoriesCritical role of ongoing EA9181 trial for Ph+ ALL highlighted in Blood Cancers Today
January 5, 2025 January 5, 2025Categories News StoriesNCI’s myeloMATCH precision medicine initiative pushes the envelop in myeloid leukemia care
October 30, 2024 October 30, 2024Categories News StoriesECOG-ACRIN and Caris partner to learn more from the TAILORx trial
October 25, 2024 October 25, 2024Categories News StoriesECOG-ACRIN and Caris to analyze samples from TAILORx (requires free registration)
October 24, 2024 October 24, 2024Categories AnnouncementsThe October 2024 News from ECOG-ACRIN blog is now available
October 24, 2024 October 24, 2024Categories Press ReleasesPress Release: ECOG-ACRIN and Caris Life Sciences partner to interrogate landmark TAILORx breast cancer trial
October 23, 2024 October 23, 2024Categories Press ReleasesPress Release: myeloMATCH precision medicine trials in myeloid leukemias open to patient enrollment across the US and Canada
September 20, 2024 September 20, 2024Categories AnnouncementsThe September 2024 News from ECOG-ACRIN blog is now available
September 18, 2024 September 18, 2024Categories Press ReleasesPress Release: Cancer Cooperative Group leaders propose a re-engineering of the nation’s correlative science program for cancer
